Paliperidone palmitate: monthly depot injection for schizophrenia

    loading  Checking for direct PDF access through Ovid

Abstract

KEY POINTS

Paliperidone palmitate is a long-acting antipsychotic injection that has recently been licensed for use in the management of schizophrenia. The authors describe its properties and the trial evidence for its efficacy and safety, and consider its place in the management of schizophrenia.

Related Topics

    loading  Loading Related Articles